Lees - Bvvde
Lees - Bvvde Lees - Bvvde
3 8 3 3 (5 ) - - 77 - /.// - 3 8 3 8 3 757 8 ; - % ,7*( 1.080 13% 1.258 15% 7,( 4.647 16% 4.777 16% *7,(& 2.771 11% 2.589 10% ,7*( 1.146 13% 1.553 18% 7,( 4.435 15% 4.652 16% *7,(& 2.566 10% 2.601 10% ,7*( 462 5% 769 9% 7,( 2.036 7% 2.083 7% *7,(& 1.012 4% 984 4% ,7*( 40 0,5% 69 0,8% 7,( 145 0,5% 242 0,8% *7,(& 104 0,4% 162 0,6% ,7*( 41 0,5% 140 1,6% 7,( 425 1,5% 526 1,8% *7,(& 148 0,6% 197 0,8% 7 %;' H + + - 1 - - ' 2 > ( ) - - 77 4 > % ,7*( 697 8% 878 10% 7,( 2.532 9% 2.761 10% *7,(& 2.480 10% 2.292 9%
( " ' ( 0 +- - + 0 + $ +- 1 ' + + - 0 -- 0 1- 0 " 0 " " - / 1 + - " 0 ' ( + - 0 - " - " 1 / ' ( - + / - + L " ' )) / 1" " EE ' = - - + 0 + - + - " " + ' + - - " ' EE 44 ( , 0 0 / ' ( + + " / - - , + ' ( " - + 0 + # - ' N - - , " " ' B . H 0 H # 5 16 $ - - II 5 )6 • 8 / 1 99 1 ; S ;%S # 3 4' ( / - EE ' . 0 H ( + & / + ' = " ' • H 0 0 1 "-- + 0 + ' = - / 3 # S < S4 0 0 3 ;S $ S4 ' ( / 0 1< 1< 0 ' • 8 / " 1 ' ( + +" - - 3 ;S #$S4 3#S $S4+ ' • ( ' 8 / 1 , .. #
- Page 2 and 3: ! " #$# % & """' ' ( " ) ' * +' ' ,
- Page 4 and 5: III.4.2. Renale complicaties 51 III
- Page 6 and 7: VI.22.1. diuretica en/of bèta-blok
- Page 8 and 9: ++ ## ( + - 1+ 0 721 ), $ - - . / (
- Page 10 and 11: ) • 8 $ +- 1 - - 0 ' • ( C " /
- Page 12 and 13: ' 2 %' K ' K ' K ' ' K ' N ' H + P
- Page 14 and 15: o - - ? o ? o ? o , , ? o , ? o , R
- Page 16 and 17: ) 4 $ $ D # B B;; " 0 0 0 ' & 3B 4
- Page 18 and 19: ( 0 - - ) • 8 " - - ' 0 3 0 ' ' ;
- Page 20 and 21: B ' & - #' ( - ; + B B;; ' ( $ - '
- Page 22 and 23: ' ( # 1 ' 7 -0 ' N C " - / 0 0 #' 2
- Page 24 and 25: • ) - . 4 ! . ! ,+(( (*+)( )*+& ,
- Page 26 and 27: aantal consultaties bij huisarts en
- Page 28 and 29: • D < - 0 - 0) & /0 / 1# 1 #' 0 0
- Page 30 and 31: ) - - 77 8 8 . . - 8 8 . aantal kla
- Page 32 and 33: 1 7 3 0 1 0 0 4' • " # + . 8 8 8
- Page 34 and 35: • J - : - 0 + - + - - 3+ 4' ( 0 -
- Page 36 and 37: %39& %' • " # D $ / 99 0 - ' #
- Page 38 and 39: • " # D ; 0 0 / # - - 99 0 , + +
- Page 40 and 41: 1 1 8 (( 2 )+ ' • " # D # / 1 # -
- Page 42 and 43: 1 8 ? 1 8 ) :: !! ( - + #'%' 7 '
- Page 44 and 45: o C D E P B 99 , R L - 1 S S #' & -
- Page 46 and 47: o J % - - , ) - - , , 1 - - , 1; -
- Page 48 and 49: 1 @ ! 7 # ' • " # ' N " / - - 1 "
- Page 50 and 51: (( %$&8 88 " % ,7*( 1.940 23% 3.18
- Page 54 and 55: - ' #1 1 - ; S 3#
- Page 56 and 57: - I S - ' - 2 - + ) - 3 , , 4 - - ,
- Page 58 and 59: 0 -- #' -- # " 0 - - / 1" " - " " -
- Page 60 and 61: omschreven voorwaarden voor tegemoe
- Page 62 and 63: In het revalidatieconcept worden mi
- Page 64 and 65: Worden hiermee uit oogpunt van prev
- Page 66 and 67: HET VOORSCHRIJVEN VAN HET INDIVIDUE
- Page 68 and 69: Artikel 13. §1. De prijzen en hono
- Page 70 and 71: Artikel 19. §1. De verantwoordelij
- Page 72 and 73: - - 44 ** ) ( 4 '* # 1 '* -0 - . 77
- Page 74 and 75: 11 %% 1 ) # H $ Huisarts 101010 Con
- Page 76 and 77: 104436 Visite effectuée par le mé
- Page 78 and 79: 1 , 761235 761246 761132 761143 761
- Page 80 and 81: 1 1 $ 4 4 @ ! " 3 4 4A . ! " 3 4 49
- Page 82 and 83: A B4 5 !+ 3 " 3 A B C + 3 " 3 < ( 3
- Page 84 and 85: 1 8 ? 8 " 3 3 A 3 0 8 " 3 A 115 5 e
- Page 86 and 87: 88 %% 8 ) +$ 8 1(9+4- 1(99)1 : 1(94
- Page 88 and 89: 8 1 Angiografieën (6')+' (6')9( An
- Page 90 and 91: (24+'' (24+(( Examen duplex couleur
- Page 92 and 93: Amputaties 289951 289962 Amputation
- Page 94 and 95: 8 ; - 651755 651770 Prothèse défi
- Page 97 and 98: ) !! !! !! ( 0 - - 1 B 1B;;1BPN' 8
- Page 99 and 100: @@ ) - ) - ) - 8 3 + 7HI ! 3 7H8I 8
- Page 101 and 102: FF ## F ) # 4 # ) - . ! ! ! ,+(( (*
3 8<br />
3<br />
3<br />
(5 ) - - 77 - /.//<br />
-<br />
3 8<br />
3 8<br />
3<br />
757<br />
8 ; -<br />
%<br />
,7*( 1.080 13% 1.258 15%<br />
7,( 4.647 16% 4.777 16%<br />
*7,(& 2.771 11% 2.589 10%<br />
,7*( 1.146 13% 1.553 18%<br />
7,( 4.435 15% 4.652 16%<br />
*7,(& 2.566 10% 2.601 10%<br />
,7*( 462 5% 769 9%<br />
7,( 2.036 7% 2.083 7%<br />
*7,(& 1.012 4% 984 4%<br />
,7*( 40 0,5% 69 0,8%<br />
7,( 145 0,5% 242 0,8%<br />
*7,(& 104 0,4% 162 0,6%<br />
,7*( 41 0,5% 140 1,6%<br />
7,( 425 1,5% 526 1,8%<br />
*7,(& 148 0,6% 197 0,8%<br />
7 %;' H + + - 1 -<br />
- '<br />
2 ><br />
( ) - - 77 4 ><br />
%<br />
,7*( 697 8% 878 10%<br />
7,( 2.532 9% 2.761 10%<br />
*7,(& 2.480 10% 2.292 9%